Evidence map›Paper›PMID 24082023›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2013

A Canadian screening program for hepatitis C: is now the time?

Hemant A Shah, Jenny Heathcote, Jordan J Feld

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Recommendations on hepatitis C screening for adults.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Guideline
  2. Guideline
  3. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identifying those infected with hepatitis C virus.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Article
  12. Article
  13. Dual sexual and drug-related predictors of hepatitis C incidence among sex workers in a Canadian setting: gaps and opportunities for scale-up of hepatitis C virus prevention, treatment, and care.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2017
    Article
  14. A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers.Canadian journal of gastroenterology & hepatology · 2017
    Article
  15. Article
  16. Comment on "Hepatitis C and the Sex Trade".Canadian journal of gastroenterology & hepatology · 2016
    Article
  17. Cost-effectiveness of screening for hepatitis C in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015
    Article
  18. Article
  19. Burden of disease and cost of chronic hepatitis C infection in Canada.Canadian journal of gastroenterology & hepatology · 2014
    Review
  20. Screening for HCV.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Hemant A Shah
Jenny Heathcote
Jordan J Feld

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mass ScreeningAge FactorsCanadaCost-Benefit AnalysisHepatitis CHumansMiddle AgedRisk AssessmentRisk Factors

Identifiers

PMID24082023
PMCPMC3796597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.